NFKB2 and Respiratory tract infection: Characterizing first-degree relatives of the present patients with frequent or severe respiratory tract infection, studying the effects of IgG replacement therapy in the present patients, and performing analyses to identify mutations in NFKB2, CXCR4, TACI, CTLA4, STAT, PI3KCD, or other genes were beyond the scope of this study.